NM_001754.5:c.342C>A
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP2BP4BA1
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.342C>A (p.Ile114=) is a synonymous variant. This variant has a MAF of 0.00256 (0.256%, 47/18362, 47 alleles) in the East Asian gnomAD cohort is ≥ 0.0015 (0.15%) (BA1). Variant observed in homozygous state (1) in gnomAD v2.1.1 and v3.1.2. (BP2). This variant is not a missense variant therefore REVEL score is not applicable and SpliceAI is ≤0.50 (0.00) (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014548/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152248Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000197 AC: 49AN: 248918 AF XY: 0.000185 show subpopulations
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1461028Hom.: 1 Cov.: 35 AF XY: 0.0000688 AC XY: 50AN XY: 726832 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152366Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74518 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Benign:1
NM_001754.5(RUNX1):c.342C>A (p.Ile114=) is a synonymous variant. This variant has a MAF of 0.00256 (0.256%, 47/18362, 47 alleles) in the East Asian gnomAD cohort is ≥ 0.0015 (0.15%) (BA1). Variant observed in homozygous state (1) in gnomAD v2.1.1 and v3.1.2. (BP2). This variant is not a missense variant therefore REVEL score is not applicable and SpliceAI is ≤0.50 (0.00) (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2, BP4. -
Hereditary cancer-predisposing syndrome Benign:1
- -
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at